
Corbus Pharmaceuticals Set to Showcase at Guggenheim SMID Cap Biotech Conference
Corbus Pharmaceuticals’ CEO to Speak at Guggenheim SMID Cap Biotech Conference NORWOOD, Mass., January 28, 2025 – Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), a clinical-stage drug development company focusing on transformative medicines for chronic and rare diseases, announced today that Yuval Cohen, Ph.D., Chief Executive Officer, will be participating in the Guggenheim SMID Cap Biotech…